View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 10, 2019updated 02 Nov 2021 7:20am

Eye care devices business Alcon becomes independent entity

Alcon has separated from its parent company Novartis and started operating as a standalone, publicly traded entity.

Alcon has separated from its parent company Novartis and started operating as a standalone, publicly traded entity.

Alcon focuses on the development of eye care devices, with businesses in surgical and vision care sectors. It operates across 74 countries.

Following the separation, Alcon plans to expand into additional markets and launch new business models. The company’s shares have already started trading on the SIX Swiss Exchange and New York Stock Exchange (NYSE).

“We are poised to achieve sustainable growth and create long-term shareholder value as a standalone company.”

As per the terms of the spin-off, each Novartis shareholder or American Depositary Receipt (ADR) holder will get one Alcon share for every five Novartis or ADR shares they held as of 1 April 2019.

Alcon’s facilities in Fort Worth, Texas, will continue as an operational centre and innovation hub.

Alcon CEO David Endicott said: “We are poised to achieve sustainable growth and create long-term shareholder value as a standalone company.

“We have a long history of industry firsts and, as a nimble medical device company, we are sharply focused on providing innovative products that meet the needs of our customers, patients and consumers.”

Last year, the company generated $7.1bn in sales, including $4bn and $3.1bn in its surgical and vision businesses, respectively.

Novartis CEO Vas Narasimhan said: “Alcon has demonstrated consistent growth, and is coming to market from a position of strength. At Novartis, we continue to reimagine ourselves as a leading medicines company powered by breakthrough medicines, data science and advanced therapy platforms.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network